Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESR1
|
ENSG00000091831.17 | estrogen receptor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_152011385_152011536 | ESR1 | 171 | 0.968833 | -0.80 | 1.0e-02 | Click! |
chr6_152012412_152012563 | ESR1 | 856 | 0.711449 | 0.79 | 1.1e-02 | Click! |
chr6_152023478_152023738 | ESR1 | 11977 | 0.261429 | -0.78 | 1.3e-02 | Click! |
chr6_152129326_152129477 | ESR1 | 587 | 0.795068 | 0.78 | 1.4e-02 | Click! |
chr6_152290545_152290696 | ESR1 | 88828 | 0.094008 | 0.78 | 1.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_20134359_20134761 | 0.80 |
NAV2-AS1 |
NAV2 antisense RNA 1 |
7618 |
0.23 |
chr3_159572255_159572681 | 0.75 |
SCHIP1 |
schwannomin interacting protein 1 |
1740 |
0.37 |
chr7_29605198_29605734 | 0.67 |
PRR15 |
proline rich 15 |
400 |
0.84 |
chr17_40670908_40671198 | 0.66 |
ENSG00000265611 |
. |
4847 |
0.09 |
chr1_36808619_36809165 | 0.66 |
STK40 |
serine/threonine kinase 40 |
18049 |
0.12 |
chr10_73605525_73605859 | 0.60 |
ENSG00000238446 |
. |
1141 |
0.49 |
chr10_81029619_81029967 | 0.58 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
36182 |
0.19 |
chr5_1515989_1516747 | 0.58 |
LPCAT1 |
lysophosphatidylcholine acyltransferase 1 |
7724 |
0.23 |
chr8_10590583_10590855 | 0.55 |
SOX7 |
SRY (sex determining region Y)-box 7 |
2697 |
0.21 |
chr10_115438620_115438948 | 0.55 |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
158 |
0.96 |
chr14_69407567_69407834 | 0.55 |
ACTN1 |
actinin, alpha 1 |
6565 |
0.25 |
chr14_105860468_105860995 | 0.55 |
PACS2 |
phosphofurin acidic cluster sorting protein 2 |
2935 |
0.17 |
chr20_30147783_30148009 | 0.52 |
HM13-IT1 |
HM13 intronic transcript 1 (non-protein coding) |
3073 |
0.16 |
chr14_59827605_59828209 | 0.51 |
ENSG00000252869 |
. |
38834 |
0.18 |
chr16_31142356_31142648 | 0.50 |
RP11-388M20.2 |
|
252 |
0.77 |
chr18_43209000_43209203 | 0.49 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
14335 |
0.2 |
chr3_183265897_183266131 | 0.45 |
KLHL6-AS1 |
KLHL6 antisense RNA 1 |
509 |
0.77 |
chr17_62151470_62151864 | 0.45 |
ICAM2 |
intercellular adhesion molecule 2 |
53673 |
0.09 |
chr7_92393722_92393991 | 0.44 |
ENSG00000206763 |
. |
62728 |
0.11 |
chr13_75990856_75991087 | 0.43 |
TBC1D4-AS1 |
TBC1D4 antisense RNA 1 |
39541 |
0.17 |
chr3_52105187_52105355 | 0.43 |
LINC00696 |
long intergenic non-protein coding RNA 696 |
7704 |
0.13 |
chr1_22258402_22258722 | 0.43 |
HSPG2 |
heparan sulfate proteoglycan 2 |
5228 |
0.16 |
chr1_9498721_9499110 | 0.41 |
ENSG00000252956 |
. |
1078 |
0.6 |
chr4_8192745_8193409 | 0.41 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
8014 |
0.22 |
chr17_55976704_55976873 | 0.41 |
CUEDC1 |
CUE domain containing 1 |
3962 |
0.21 |
chr1_6532022_6532173 | 0.41 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
5842 |
0.12 |
chr1_153598933_153599084 | 0.41 |
S100A13 |
S100 calcium binding protein A13 |
516 |
0.52 |
chr9_137270522_137271255 | 0.41 |
ENSG00000263897 |
. |
369 |
0.9 |
chr14_69412745_69412910 | 0.40 |
ACTN1 |
actinin, alpha 1 |
1438 |
0.48 |
chr3_50355712_50356133 | 0.40 |
HYAL2 |
hyaluronoglucosaminidase 2 |
2457 |
0.1 |
chr16_11295208_11295453 | 0.40 |
RMI2 |
RecQ mediated genome instability 2 |
48176 |
0.08 |
chr22_43318424_43318765 | 0.40 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
23285 |
0.2 |
chr6_20877296_20877733 | 0.40 |
RP3-348I23.2 |
|
76589 |
0.12 |
chr14_89894960_89895143 | 0.40 |
FOXN3-AS1 |
FOXN3 antisense RNA 1 |
11353 |
0.17 |
chr1_55518675_55518972 | 0.40 |
PCSK9 |
proprotein convertase subtilisin/kexin type 9 |
12928 |
0.2 |
chr2_9392225_9392385 | 0.39 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
45411 |
0.18 |
chr17_79971752_79971903 | 0.39 |
ASPSCR1 |
alveolar soft part sarcoma chromosome region, candidate 1 |
3140 |
0.09 |
chr17_36740635_36740786 | 0.39 |
CTB-58E17.2 |
|
16592 |
0.13 |
chr14_103578139_103578290 | 0.39 |
EXOC3L4 |
exocyst complex component 3-like 4 |
4361 |
0.19 |
chr11_46360145_46360296 | 0.39 |
DGKZ |
diacylglycerol kinase, zeta |
72 |
0.97 |
chr20_61463306_61463766 | 0.38 |
COL9A3 |
collagen, type IX, alpha 3 |
14373 |
0.11 |
chr11_63640497_63640654 | 0.38 |
MARK2 |
MAP/microtubule affinity-regulating kinase 2 |
3827 |
0.17 |
chr10_30101231_30101626 | 0.38 |
SVIL |
supervillin |
76695 |
0.11 |
chr9_136996353_136996504 | 0.38 |
WDR5 |
WD repeat domain 5 |
4059 |
0.19 |
chr8_123928226_123928643 | 0.37 |
ZHX2 |
zinc fingers and homeoboxes 2 |
52810 |
0.12 |
chr1_27868563_27868910 | 0.37 |
RP1-159A19.4 |
|
16420 |
0.16 |
chr8_129180533_129180792 | 0.37 |
ENSG00000221261 |
. |
18300 |
0.23 |
chr16_66544956_66545128 | 0.37 |
TK2 |
thymidine kinase 2, mitochondrial |
2644 |
0.17 |
chr22_30194899_30195349 | 0.37 |
ASCC2 |
activating signal cointegrator 1 complex subunit 2 |
2967 |
0.2 |
chr1_21588447_21588832 | 0.37 |
RP3-329E20.2 |
|
3936 |
0.22 |
chr2_8640925_8641201 | 0.37 |
AC011747.7 |
|
174833 |
0.03 |
chr2_9427415_9427711 | 0.36 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
80669 |
0.1 |
chr2_131111615_131111766 | 0.36 |
PTPN18 |
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
1890 |
0.27 |
chr12_109115682_109115890 | 0.36 |
CORO1C |
coronin, actin binding protein, 1C |
8541 |
0.16 |
chr15_40627004_40627253 | 0.36 |
C15orf52 |
chromosome 15 open reading frame 52 |
3113 |
0.1 |
chr3_11243097_11243459 | 0.36 |
HRH1 |
histamine receptor H1 |
24439 |
0.24 |
chr20_34685745_34686271 | 0.36 |
EPB41L1 |
erythrocyte membrane protein band 4.1-like 1 |
5249 |
0.2 |
chr17_47533894_47534339 | 0.36 |
NGFR |
nerve growth factor receptor |
38539 |
0.1 |
chr14_65293424_65293575 | 0.36 |
SPTB |
spectrin, beta, erythrocytic |
3633 |
0.24 |
chr10_126029460_126029611 | 0.36 |
OAT |
ornithine aminotransferase |
77970 |
0.1 |
chr1_22258230_22258381 | 0.36 |
HSPG2 |
heparan sulfate proteoglycan 2 |
5485 |
0.16 |
chr9_137261966_137262247 | 0.36 |
ENSG00000263897 |
. |
9151 |
0.25 |
chr11_12088585_12089097 | 0.36 |
MICAL2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
26702 |
0.22 |
chr8_142289717_142289880 | 0.35 |
RP11-10J21.3 |
Uncharacterized protein |
25134 |
0.12 |
chr19_41731212_41731363 | 0.35 |
AXL |
AXL receptor tyrosine kinase |
1373 |
0.29 |
chr1_184761453_184761811 | 0.35 |
FAM129A |
family with sequence similarity 129, member A |
13487 |
0.2 |
chr9_139257302_139257550 | 0.35 |
DNLZ |
DNL-type zinc finger |
745 |
0.51 |
chr17_55954346_55954647 | 0.35 |
CUEDC1 |
CUE domain containing 1 |
4465 |
0.2 |
chr3_50176368_50176664 | 0.35 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
15962 |
0.12 |
chr3_72235398_72235672 | 0.34 |
ENSG00000212070 |
. |
76044 |
0.12 |
chr17_79378177_79378500 | 0.34 |
ENSG00000266392 |
. |
3760 |
0.14 |
chr7_151385205_151385463 | 0.34 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
48015 |
0.15 |
chr1_42627613_42628057 | 0.34 |
GUCA2A |
guanylate cyclase activator 2A (guanylin) |
2554 |
0.29 |
chr14_69405435_69405631 | 0.34 |
ACTN1 |
actinin, alpha 1 |
8732 |
0.24 |
chr4_139327703_139328022 | 0.34 |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
164359 |
0.04 |
chr11_62380549_62380700 | 0.34 |
ROM1 |
retinal outer segment membrane protein 1 |
377 |
0.4 |
chr21_38232225_38232376 | 0.34 |
ENSG00000199806 |
. |
8089 |
0.23 |
chr6_8083142_8083550 | 0.34 |
EEF1E1 |
eukaryotic translation elongation factor 1 epsilon 1 |
14198 |
0.22 |
chr6_15222233_15222384 | 0.34 |
JARID2 |
jumonji, AT rich interactive domain 2 |
24219 |
0.18 |
chr11_64878272_64878458 | 0.34 |
VPS51 |
vacuolar protein sorting 51 homolog (S. cerevisiae) |
411 |
0.47 |
chr8_96238091_96238242 | 0.34 |
C8orf37 |
chromosome 8 open reading frame 37 |
43263 |
0.17 |
chr20_1317307_1317796 | 0.33 |
AL136531.1 |
HCG2043693; Uncharacterized protein |
4 |
0.97 |
chr9_130906009_130906346 | 0.33 |
LCN2 |
lipocalin 2 |
5173 |
0.09 |
chr11_111609200_111609351 | 0.33 |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
16487 |
0.17 |
chr22_30648620_30649241 | 0.33 |
LIF |
leukemia inhibitory factor |
6090 |
0.11 |
chr2_169426823_169427210 | 0.33 |
ENSG00000265694 |
. |
12437 |
0.23 |
chr19_2636442_2636925 | 0.33 |
CTC-265F19.3 |
|
4731 |
0.15 |
chr1_47691411_47691617 | 0.33 |
RP1-18D14.7 |
|
45 |
0.97 |
chr9_94533727_94534271 | 0.33 |
ENSG00000266855 |
. |
135466 |
0.05 |
chr2_43152306_43152732 | 0.33 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
132787 |
0.05 |
chr22_45625921_45626224 | 0.33 |
KIAA0930 |
KIAA0930 |
3288 |
0.23 |
chr4_151097529_151097680 | 0.33 |
ENSG00000238721 |
. |
33254 |
0.22 |
chr11_10609186_10609457 | 0.33 |
MRVI1-AS1 |
MRVI1 antisense RNA 1 |
5423 |
0.19 |
chr22_44759775_44760116 | 0.33 |
RP1-32I10.10 |
Uncharacterized protein |
1486 |
0.51 |
chr17_1655742_1656238 | 0.33 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
9263 |
0.1 |
chr1_3633020_3633399 | 0.33 |
RP5-1092A11.2 |
|
2347 |
0.18 |
chr6_133085395_133085546 | 0.32 |
VNN2 |
vanin 2 |
872 |
0.48 |
chr18_46510269_46510564 | 0.32 |
SMAD7 |
SMAD family member 7 |
33335 |
0.16 |
chr1_151579139_151579290 | 0.32 |
SNX27 |
sorting nexin family member 27 |
5344 |
0.12 |
chr10_80850413_80850863 | 0.32 |
ZMIZ1 |
zinc finger, MIZ-type containing 1 |
21846 |
0.22 |
chr17_55967739_55968110 | 0.32 |
CUEDC1 |
CUE domain containing 1 |
2125 |
0.29 |
chr19_5260963_5261211 | 0.32 |
PTPRS |
protein tyrosine phosphatase, receptor type, S |
25087 |
0.21 |
chr9_96919191_96919602 | 0.32 |
ENSG00000199165 |
. |
18838 |
0.15 |
chr9_124032094_124032357 | 0.32 |
GSN |
gelsolin |
1845 |
0.28 |
chr20_1842593_1842744 | 0.32 |
SIRPA |
signal-regulatory protein alpha |
32486 |
0.19 |
chr21_44614410_44614785 | 0.32 |
CRYAA |
crystallin, alpha A |
24331 |
0.16 |
chr2_65608934_65609351 | 0.32 |
AC012370.2 |
|
1323 |
0.48 |
chr22_37908037_37908429 | 0.32 |
CARD10 |
caspase recruitment domain family, member 10 |
15 |
0.97 |
chr11_19941032_19941183 | 0.32 |
NAV2-AS3 |
NAV2 antisense RNA 3 |
61776 |
0.13 |
chr1_28455497_28456106 | 0.31 |
ENSG00000253005 |
. |
13551 |
0.13 |
chr17_55981324_55981475 | 0.31 |
CUEDC1 |
CUE domain containing 1 |
649 |
0.69 |
chr16_70740874_70741025 | 0.31 |
VAC14 |
Vac14 homolog (S. cerevisiae) |
6801 |
0.15 |
chr7_129912749_129913103 | 0.31 |
CPA2 |
carboxypeptidase A2 (pancreatic) |
6259 |
0.15 |
chr14_69409711_69409862 | 0.31 |
ACTN1 |
actinin, alpha 1 |
4479 |
0.27 |
chr16_638089_638338 | 0.31 |
RAB40C |
RAB40C, member RAS oncogene family |
1144 |
0.24 |
chr9_14273530_14273681 | 0.31 |
NFIB |
nuclear factor I/B |
34407 |
0.21 |
chr19_11252797_11253239 | 0.31 |
SPC24 |
SPC24, NDC80 kinetochore complex component |
13419 |
0.13 |
chr2_241327570_241327721 | 0.31 |
GPC1 |
glypican 1 |
47443 |
0.12 |
chr3_119854481_119854726 | 0.31 |
ENSG00000244139 |
. |
13847 |
0.18 |
chr8_56861171_56861322 | 0.31 |
LYN |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
8453 |
0.16 |
chrX_152084026_152084274 | 0.31 |
ZNF185 |
zinc finger protein 185 (LIM domain) |
1116 |
0.5 |
chr1_16083104_16083325 | 0.31 |
FBLIM1 |
filamin binding LIM protein 1 |
60 |
0.95 |
chr6_7165580_7166040 | 0.31 |
RP11-405O10.2 |
|
17506 |
0.17 |
chr8_61862675_61863209 | 0.31 |
CLVS1 |
clavesin 1 |
106775 |
0.07 |
chr11_67805590_67806035 | 0.31 |
TCIRG1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
671 |
0.53 |
chr22_25460867_25461018 | 0.31 |
KIAA1671 |
KIAA1671 |
4994 |
0.26 |
chr6_138291326_138291739 | 0.31 |
RP11-356I2.4 |
|
102162 |
0.07 |
chr7_139426374_139426898 | 0.30 |
HIPK2 |
homeodomain interacting protein kinase 2 |
4795 |
0.29 |
chr13_31438557_31438708 | 0.30 |
MEDAG |
mesenteric estrogen-dependent adipogenesis |
41696 |
0.16 |
chr22_19161927_19162579 | 0.30 |
AC004463.6 |
|
3345 |
0.15 |
chr17_42423914_42424082 | 0.30 |
GRN |
granulin |
1325 |
0.25 |
chr15_62737179_62737605 | 0.30 |
TLN2 |
talin 2 |
116172 |
0.06 |
chr9_125156330_125156481 | 0.30 |
AL162424.1 |
Uncharacterized protein |
7477 |
0.13 |
chr2_121943870_121944021 | 0.30 |
TFCP2L1 |
transcription factor CP2-like 1 |
98838 |
0.08 |
chr7_55253756_55253907 | 0.30 |
EGFR-AS1 |
EGFR antisense RNA 1 |
2796 |
0.38 |
chr8_42409885_42410036 | 0.30 |
SMIM19 |
small integral membrane protein 19 |
8389 |
0.18 |
chr1_28517417_28517723 | 0.30 |
PTAFR |
platelet-activating factor receptor |
2814 |
0.15 |
chr13_52412121_52412530 | 0.30 |
CCDC70 |
coiled-coil domain containing 70 |
23792 |
0.17 |
chr3_132757241_132757419 | 0.30 |
TMEM108 |
transmembrane protein 108 |
69 |
0.99 |
chr11_65257627_65258285 | 0.30 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
34592 |
0.08 |
chr1_203172034_203172338 | 0.30 |
CHI3L1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
16309 |
0.13 |
chr9_91390340_91390723 | 0.30 |
ENSG00000265873 |
. |
29711 |
0.24 |
chr22_20191302_20191696 | 0.30 |
XXbac-B444P24.8 |
|
942 |
0.46 |
chr3_45589006_45589723 | 0.30 |
LARS2-AS1 |
LARS2 antisense RNA 1 |
38327 |
0.14 |
chr17_72782415_72782574 | 0.30 |
TMEM104 |
transmembrane protein 104 |
9835 |
0.11 |
chr16_2211619_2211770 | 0.29 |
TRAF7 |
TNF receptor-associated factor 7, E3 ubiquitin protein ligase |
1849 |
0.12 |
chr14_93403837_93403988 | 0.29 |
CHGA |
chromogranin A (parathyroid secretory protein 1) |
14391 |
0.25 |
chr11_33963443_33963781 | 0.29 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
49776 |
0.14 |
chr8_48343958_48344189 | 0.29 |
SPIDR |
scaffolding protein involved in DNA repair |
8890 |
0.29 |
chr15_33360065_33360419 | 0.29 |
FMN1 |
formin 1 |
121 |
0.98 |
chr3_63710485_63710636 | 0.29 |
SNTN |
sentan, cilia apical structure protein |
72186 |
0.09 |
chr17_76704134_76704285 | 0.29 |
CYTH1 |
cytohesin 1 |
8898 |
0.2 |
chr16_12282215_12282366 | 0.29 |
SNX29 |
sorting nexin 29 |
58736 |
0.11 |
chr1_160095186_160095337 | 0.29 |
ATP1A2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
2201 |
0.19 |
chr17_74542392_74542689 | 0.29 |
RP11-666A8.7 |
|
3493 |
0.09 |
chr1_3620112_3620445 | 0.29 |
TP73 |
tumor protein p73 |
5656 |
0.13 |
chr1_21620651_21620932 | 0.29 |
ECE1 |
endothelin converting enzyme 1 |
126 |
0.93 |
chr18_9704973_9705544 | 0.29 |
RAB31 |
RAB31, member RAS oncogene family |
2904 |
0.31 |
chr2_218793437_218793804 | 0.29 |
TNS1 |
tensin 1 |
8265 |
0.24 |
chr18_46517444_46517630 | 0.29 |
RP11-15F12.1 |
|
32536 |
0.16 |
chr2_43466747_43467191 | 0.29 |
AC010883.5 |
|
10257 |
0.23 |
chr6_17933009_17933323 | 0.29 |
KIF13A |
kinesin family member 13A |
54528 |
0.15 |
chr17_8762469_8762816 | 0.29 |
PIK3R6 |
phosphoinositide-3-kinase, regulatory subunit 6 |
8352 |
0.2 |
chr17_17740781_17741345 | 0.29 |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
738 |
0.58 |
chr1_183250951_183251102 | 0.28 |
NMNAT2 |
nicotinamide nucleotide adenylyltransferase 2 |
22983 |
0.23 |
chr2_206809249_206809511 | 0.28 |
ENSG00000201875 |
. |
44026 |
0.13 |
chr7_906996_907156 | 0.28 |
GET4 |
golgi to ER traffic protein 4 homolog (S. cerevisiae) |
9113 |
0.15 |
chr18_43749824_43749975 | 0.28 |
C18orf25 |
chromosome 18 open reading frame 25 |
3620 |
0.25 |
chr3_112931713_112931990 | 0.28 |
BOC |
BOC cell adhesion associated, oncogene regulated |
442 |
0.86 |
chr14_35806722_35806916 | 0.28 |
PSMA6 |
proteasome (prosome, macropain) subunit, alpha type, 6 |
26780 |
0.19 |
chr11_95086535_95086686 | 0.28 |
ENSG00000201204 |
. |
119928 |
0.06 |
chr11_72896529_72896905 | 0.28 |
RP11-800A3.2 |
|
30241 |
0.13 |
chr20_52235971_52236462 | 0.28 |
ZNF217 |
zinc finger protein 217 |
10785 |
0.21 |
chr6_167037122_167037303 | 0.28 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
3513 |
0.32 |
chr3_31857579_31857730 | 0.28 |
OSBPL10 |
oxysterol binding protein-like 10 |
13912 |
0.27 |
chr5_14204722_14204930 | 0.28 |
TRIO |
trio Rho guanine nucleotide exchange factor |
20919 |
0.29 |
chr5_176920924_176921139 | 0.28 |
RP11-1334A24.6 |
|
965 |
0.35 |
chr4_41144342_41144612 | 0.28 |
ENSG00000207198 |
. |
28518 |
0.18 |
chr16_70425965_70426116 | 0.28 |
ST3GAL2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
8501 |
0.12 |
chr4_128544405_128544987 | 0.28 |
INTU |
inturned planar cell polarity protein |
270 |
0.95 |
chr6_90529041_90529192 | 0.28 |
MDN1 |
MDN1, midasin homolog (yeast) |
321 |
0.87 |
chr4_3487177_3487367 | 0.28 |
RP11-529E10.6 |
|
18912 |
0.14 |
chr9_19999717_20000054 | 0.28 |
ENSG00000266224 |
. |
170134 |
0.03 |
chr1_61803481_61803729 | 0.28 |
NFIA |
nuclear factor I/A |
14517 |
0.3 |
chr3_197036693_197037063 | 0.28 |
DLG1 |
discs, large homolog 1 (Drosophila) |
10707 |
0.16 |
chr21_43352747_43353275 | 0.28 |
C2CD2 |
C2 calcium-dependent domain containing 2 |
6212 |
0.19 |
chr4_5638816_5638967 | 0.28 |
EVC2 |
Ellis van Creveld syndrome 2 |
71403 |
0.11 |
chr10_101946913_101947666 | 0.28 |
ERLIN1 |
ER lipid raft associated 1 |
802 |
0.51 |
chr6_82649464_82649641 | 0.28 |
ENSG00000206886 |
. |
175811 |
0.03 |
chr1_203482695_203483217 | 0.28 |
OPTC |
opticin |
17858 |
0.21 |
chr11_33963006_33963250 | 0.28 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
49292 |
0.14 |
chr1_203194147_203194370 | 0.28 |
CHIT1 |
chitinase 1 (chitotriosidase) |
4541 |
0.19 |
chr16_9141084_9141235 | 0.28 |
C16orf72 |
chromosome 16 open reading frame 72 |
44346 |
0.12 |
chr17_76137750_76137971 | 0.28 |
C17orf99 |
chromosome 17 open reading frame 99 |
4574 |
0.12 |
chr16_85558860_85559293 | 0.28 |
ENSG00000264203 |
. |
83978 |
0.08 |
chr12_52400893_52401105 | 0.27 |
GRASP |
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein |
275 |
0.87 |
chr5_140908442_140908593 | 0.27 |
DIAPH1 |
diaphanous-related formin 1 |
2803 |
0.16 |
chr8_65488684_65489072 | 0.27 |
RP11-21C4.1 |
|
942 |
0.63 |
chr17_80607445_80607596 | 0.27 |
WDR45B |
WD repeat domain 45B |
1109 |
0.35 |
chr9_98275007_98275158 | 0.27 |
RP11-435O5.4 |
|
1245 |
0.41 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.3 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.3 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.2 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.8 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.1 | 0.2 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.4 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.2 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.1 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.3 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.2 | GO:0002885 | positive regulation of hypersensitivity(GO:0002885) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.2 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.0 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.3 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.0 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.2 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm development(GO:0048368) regulation of mesoderm development(GO:2000380) |
0.0 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.7 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.0 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0051900 | regulation of membrane depolarization(GO:0003254) regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0045924 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.4 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.2 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.0 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.2 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.1 | GO:1903319 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0034442 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.3 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.2 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.0 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.0 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.0 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 1.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.0 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.1 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.0 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.2 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.1 | GO:0051570 | negative regulation of histone methylation(GO:0031061) regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.0 | 0.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 1.1 | GO:0034329 | cell junction assembly(GO:0034329) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.0 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.2 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.1 | GO:0006027 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.0 | 0.0 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0090312 | positive regulation of histone deacetylation(GO:0031065) positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.2 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.0 | GO:0045006 | DNA deamination(GO:0045006) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 3.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.9 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.0 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.6 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.4 | GO:0097223 | acrosomal vesicle(GO:0001669) sperm part(GO:0097223) |
0.0 | 0.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.0 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 2.2 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 1.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0008253 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0046980 | tapasin binding(GO:0046980) |
0.0 | 0.5 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.0 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.1 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.2 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |